There are some problems with regard to NFI and NNFI as they are both below the accepted threshold.
Even WeWork, the real estate-meet-startup exploding giant, is estimated by our formula to be valued at $9.1 billion, ~46percentt lower than market common value, and SpaceX at $8.2 billion is ~32percentt below the accepted threshold.
However, the q value assessment for the peaks group shown in Fig. 1d still fell below the accepted threshold of q ≤ 0.01, which allowed us to consider this and a few other similar situations as borderline but acceptable for quantitative evaluation.
This had a small effect of increasing the ICER to €267411, still below the accepted threshold.
The fraction of those reads, however, that represented the variant allele was below the accepted threshold (two reads of the total 15, 13.3% versus the filter's cutoff >20% variant allele fraction).
Regardless of the RCA-CRRT protocol, no episodes of metabolic acidosis, possibly related to inadequate citrate metabolism, were observed and Calcium Ratio resulted constantly below the accepted threshold value of 2.5.
This analysis showed that there is an 85% probability that posaconazole is a cost-saving strategy compared to SAT and that the probability that the incremental cost-effectiveness ratio for posaconazole versus SAT is below the accepted threshold in Spain (currently €30,000 per LYS) is 98%.
In the social sciences, a finding is said to be "statistically significant" if this number is below 5% or occasionally 1%; in fields like particle physics, the accepted threshold is one in many millions.
On the basis of discount rates that were applicable prior to 2004 (6% for costs, 1.5% for benefits), NICE estimated that the cost per quality-adjusted life years (QALY) of anastrozole compared with tamoxifen (£12 310/QAlay lay below the currently accepted thresholds under which interventions are considered to be cost-effective (£20K to £30K/QALY).
Additional analyses showed that over the entire age range that was examined (60 80 years), the cost effectiveness of denosumab fell below the commonly accepted threshold of €30,000 per QALY gained for women with a BMD T score ≤−2.5 or prevalent vertebral fracture.
